1. Home
  2. CVAC vs YSG Comparison

CVAC vs YSG Comparison

Compare CVAC & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • YSG
  • Stock Information
  • Founded
  • CVAC 2000
  • YSG 2016
  • Country
  • CVAC Germany
  • YSG China
  • Employees
  • CVAC N/A
  • YSG N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • YSG Package Goods/Cosmetics
  • Sector
  • CVAC Health Care
  • YSG Consumer Discretionary
  • Exchange
  • CVAC Nasdaq
  • YSG Nasdaq
  • Market Cap
  • CVAC 764.4M
  • YSG 889.0M
  • IPO Year
  • CVAC 2020
  • YSG 2020
  • Fundamental
  • Price
  • CVAC $5.45
  • YSG $9.32
  • Analyst Decision
  • CVAC Hold
  • YSG
  • Analyst Count
  • CVAC 3
  • YSG 0
  • Target Price
  • CVAC $6.83
  • YSG N/A
  • AVG Volume (30 Days)
  • CVAC 2.2M
  • YSG 974.5K
  • Earning Date
  • CVAC 08-14-2025
  • YSG 08-19-2025
  • Dividend Yield
  • CVAC N/A
  • YSG N/A
  • EPS Growth
  • CVAC N/A
  • YSG N/A
  • EPS
  • CVAC 0.87
  • YSG N/A
  • Revenue
  • CVAC $566,039,775.00
  • YSG $475,930,821.00
  • Revenue This Year
  • CVAC N/A
  • YSG $17.93
  • Revenue Next Year
  • CVAC $24.04
  • YSG $12.79
  • P/E Ratio
  • CVAC $6.31
  • YSG N/A
  • Revenue Growth
  • CVAC 787.60
  • YSG 0.90
  • 52 Week Low
  • CVAC $2.37
  • YSG $3.01
  • 52 Week High
  • CVAC $5.72
  • YSG $11.57
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 65.07
  • YSG 61.11
  • Support Level
  • CVAC $5.36
  • YSG $9.36
  • Resistance Level
  • CVAC $5.45
  • YSG $10.63
  • Average True Range (ATR)
  • CVAC 0.08
  • YSG 0.81
  • MACD
  • CVAC -0.05
  • YSG -0.17
  • Stochastic Oscillator
  • CVAC 58.00
  • YSG 35.43

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

Share on Social Networks: